Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gynecologic Oncology

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/GYNO.2001.6308PMID 11585414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different expression patterns of cyclins A, D1 and E in human colorectal cancer

  2005cited by this paper
• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.

  2000cited by this paper
• Inverse expression of Cdk4 and p16 in epithelial ovarian tumors.

  2000cited by this paper
• The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.

  1999cited by this paper
• Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.

  1999cited by this paper
• Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells

  1999cited by this paper
• Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.

  1999cited by this paper
• Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.

  1999cited by this paper
• Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors.

  1999cited by this paper
• The Concurrent Expression of p27kip1and Cyclin D1 in Epithelial Ovarian Tumors

  1999cited by this paper
• Chemotherapy of advanced ovarian cancer.

  1998cited by this paper
• Prognostic value of cyclin E and p53 expression in gastric carcinoma

  1998cited by this paper
• Low p27 expression predicts poor disease-free survival in patients with prostate cancer.

  1998cited by this paper
• Chemotherapy of advanced ovarian cancer.

  1998cited by this paper
• Management of early ovarian cancer.

  1998cited by this paper
• Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.

  1998cited by this paper
• p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas.

  1998cited by this paper
• Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.

  1998cited by this paper
• Analysis of cyclin E and CDK2 in ovarian cancer: Gene amplification and RNA overexpression

  1998cited by this paper
• Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma.

  1998cited by this paper
• Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas

  1997cited by this paper
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• Aberrant p27kip1 expression in endocrine and other tumors.

  1997cited by this paper
• Overexpression of cyclin D1 in epithelial ovarian cancers.

  1997cited by this paper
• Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

  1997cited by this paper
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

  1997cited by this paper
• p27 expression and gastric carcinoma

  1997cited by this paper
• Expression of cyclin D1 correlates with malignancy in human ovarian tumours.

  1997cited by this paper
• Cell cycle and cancer: critical events at the G1 restriction point.

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors

  1996cited by this paper
• Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status.

  1996cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

  1995cited by this paper
• The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.

  1995cited by this paper
• The epidemiology of ovarian cancer

  1995cited by this paper
• Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas

  1995cited by this paper
• Cyclin E, a potential prognostic marker for breast cancer.

  1994cited by this paper
• G1 phase progression: cycling on cue.

  1994cited by this paper

• p27Kip1 and cytoplasmic pSer10p27 are promising biomarkers for predicting prognosis and chemotherapy response in ovarian cancer.

  2024cites this paper
• The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers

  2024cites this paper
• Scutellaria baicalensis Georgi and Their Natural Flavonoid Compounds in the Treatment of Ovarian Cancer: A Review

  2023cites this paper
• Could cannabinoids provide a new hope for ovarian cancer patients?

  2023cites this paper
• Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin

  2021cites this paper
• Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives

  2021cites this paper
• SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway

  2021cites this paper
• NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2

  2020cites this paper
• High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer

  2020cites this paper
• Schizandrin A inhibits cellular phenotypes of breast cancer cells by repressing miR‐155

  2020cites this paper
• The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis

  2018cites this paper
• Predicting the outcome of oral, potentially malignant, disorders using a composite clinical, histopathological and molecular classifier

  2018cites this paper
• Mifepristone is a valuable therapeutic alternative in oncology

  2018cites this paper
• Expression of RNA-binding Motif Protein 3 (RBM3) and Cold-inducible RNA-binding protein (CIRP) Is Associated with Improved Clinical Outcome in Patients with Colon Cancer.

  2017cites this paper
• Importancia de la temperatura de la quimioterapia intraperitoneal intraoperatoria con paclitaxel en el tratamiento quirúrgico radical de la carcinomatosis peritoneal de origen ovárico. Hipertermia versus normotermia

  2017cites this paper
• Antineoplastic Effects of Honokiol on Melanoma

  2017cites this paper
• 11 Antiprogestins in Ovarian Cancer

  2017cites this paper
• Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo

  2016cites this paper
• Hypo/unmethylated promoter status of Cdk2 gene correlates with its over-expression in ovarian cancer in north Indian population.

  2016cites this paper
• Application of graph models in bioinformatics

  2016cites this paper
• Propagation on Molecular Interaction Networks: Prediction of Effective Drug Combinations and Biomarkers in Cancer Treatment.

  2016cites this paper
• Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression

  2015influential citation
• RNA Interference of Biot2 Induces G1 Phase Arrest and Apoptosis in Mouse Colorectal Cancer Cell Line

  2015cites this paper
• Antiprogestins in gynecological diseases

  2014cites this paper
• Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.

  2014cites this paper
• Mifepristone : A prototypical antiprogestin

  2014cites this paper
• Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability

  2014cites this paper
• The Role of CDK2 and CDK9 in the Radiation Response of human HNSCC Cancer Cells

  2013cites this paper
• Biomedical hypothesis generation by text mining and gene prioritization.

  2013cites this paper
• Ovarian cancer as a genetic disease.

  2013cites this paper
• Exploring the Oncogenic Role of p27 in Regulating Tumor Progression

  2013cites this paper
• Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases

  2013influential citation
• Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish ‘MALOVA’ ovarian cancer study

  2012cites this paper
• Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

  2012cites this paper
• Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

  2012cites this paper
• Prognostic value of biomarkers related to drug resistance in patients with advanced epithelial ovarian cancer.

  2012cites this paper
• Antiprogestins in Ovarian Cancer

  2012cites this paper
• Generation and characterisation of novel monoclonal antibodies towards ovarian tumour stem cells

  2012cites this paper
• Altered expression of p27Kip1‐interacting cell‐cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression

  2012cites this paper
• Distinct Expression Pattern and Post-Transcriptional Regulation of Cell Cycle Genes in the Glandular Epithelia of Avian Ovarian Carcinomas

  2012cites this paper
• Cyclin E low-molecular-weight isoform as a predictor of breast cancer in Japanese women.

  2011cites this paper
• Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2

  2011cites this paper
• Significance of Cell Cycle Regulatory Proteins as Malignant and Prognostic Biomarkers in Ovarian Epithelial Tumors

  2011cites this paper
• Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.

  2011cites this paper
• Les dysplasies tubo-ovariennes : contribution à une meilleure compréhension de la carcinogenèse ovarienne

  2011cites this paper
• The expression of human epididymis protein 4 and cyclin- dependent kinase inhibitor p27Kip1 in human ovarian carcinoma

  2011cites this paper
• p27 and Metastatic Progression: Molecular Mechanisms Underlying Bone Metastasis

  2011cites this paper
• The expression of human epididymis protein 4 and cyclindependent kinase inhibitor p27Kip1 in human ovarian carcinoma

  2011cites this paper
• Immunoediting and angiogenesis in ovarian cancer

  2010cites this paper
• Host cell factors in ovarian cancer influencing efficacy of oncolytic aenovirus dl922-947

  2010cites this paper
• p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies

  2010cites this paper
• Cumulative alterations of p27Kip1‐related cell‐cycle regulators in the development of endometriosis‐associated ovarian clear cell adenocarcinoma

  2010cites this paper
• Cold‐inducible RNA‐binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer

  2010cites this paper
• Microenvironment and Pathogenesis of Epithelial Ovarian Cancer

  2010cites this paper
• Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer

  2010cites this paper
• Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies

  2010cites this paper
• Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target.

  2010cites this paper
• Prognostic biomarkers in ovarian cancer

  2010cites this paper
• Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.

  2009influential citation
• Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients

  2009cites this paper
• Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.

  2009influential citation
• Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression

  2009cites this paper
• Cell cycle control as a basis for cancer chemoprevention through dietary agents.

  2008cites this paper
• Early events in the pathogenesis of epithelial ovarian cancer.

  2008cites this paper
• Analysis of Gene Expression in Early-Stage Ovarian Cancer

  2008cites this paper
• The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

  2008cites this paper
• Loss of Nuclear p 27 Expression and Its Prognostic Role in Relation to Cyclin E and p 53 Mutation in Gastroenteropancreatic NeuroendocrineTumors

  2008cites this paper
• Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors

  2008cites this paper
• Identification of breast cancer peptide epitopes presented by HLA-A*0201.

  2008cites this paper
• Low‐molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma

  2007cites this paper
• Skp2 is an independent prognosticator of gallbladder carcinoma among p27Kip1-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray

  2007cites this paper
• Expression and Prognostic Significance of Cyclin D3 in Ovarian Adenocarcinomas

  2007cites this paper
• The Role of Cyclin E and its Lower Molecular Forms in the Oncogenesis of Ovarian Cancer and its Predictive Value in Patients with Early Stage Ovarian Tumor

  2007cites this paper
• Molecular Markers in Epithelial Ovarian Cancer

  2007cites this paper
• Progress in the Development of Agents to Control the Cell Cycle

  2007cites this paper
• The role of cell cycle genes in The diagnosis and Therapy of ovarian cancer

  2007cites this paper
• Mifepristone Inhibits Ovarian Cancer Cell Growth In vitro and In vivo

  2007cites this paper
• Alteration of cell-cycle regulation in epithelial ovarian cancer

  2007cites this paper
• Cyclin E–Associated Kinase Activity Predicts Response to Platinum-Based Chemotherapy

  2007cites this paper
• Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles' heel?

  2007cites this paper
• Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.

  2006cites this paper
• Mouse models of cell cycle regulators: new paradigms.

  2006cites this paper
• Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer

  2006cites this paper
• Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma

  2006cites this paper
• Gene Expression Signatures Differentiate Ovarian / Peritoneal Serous Carcinoma from DiffuseMalignant Peritoneal Mesothelioma

  2006cites this paper
• Clinical significance of Skp 2 expression , alone and combined with Jab 1 and p 27 in epithelial ovarian tumors

  2006cites this paper
• Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.

  2006cites this paper
• Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma

  2006cites this paper
• Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays.

  2006cites this paper
• HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.

  2006cites this paper
• Current controversies in the biology and management of ovarian tumors of low malignant potential

  2006cites this paper
• Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.

  2005cites this paper
• Expression of the c‐Met in advanced epithelial ovarian cancer and its prognostic significance

  2005cites this paper
• Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.

  2005cites this paper
• Effect of Cell Cycle Inhibition on Cisplatin-Induced Cytotoxicity

  2005cites this paper
• Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling

  2005cites this paper
• Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.

  2005cites this paper
• Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance

  2004cites this paper
• Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 (Kip1) in estrogen-related endometrial adenocarcinomas

  2004cites this paper
• p27/Kip1 mediates retinoic acid‐induced suppression of ovarian carcinoma cell growth

  2004cites this paper